14
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Identification and characterization of a missense mutation in the O-linked β- N-acetylglucosamine ( O-GlcNAc) transferase gene that segregates with X-linked intellectual disability

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          O-GlcNAc is a regulatory post-translational modification of nucleocytoplasmic proteins that has been implicated in multiple biological processes, including transcription. In humans, single genes encode enzymes for its attachment ( O-GlcNAc transferase (OGT)) and removal ( O-GlcNAcase (OGA)). An X-chromosome exome screen identified a missense mutation, which encodes an amino acid in the tetratricopeptide repeat, in OGT (759G>T (p.L254F)) that segregates with X-linked intellectual disability (XLID) in an affected family. A decrease in steady-state OGT protein levels was observed in isolated lymphoblastoid cell lines from affected individuals, consistent with molecular modeling experiments. Recombinant expression of L254F-OGT demonstrated that the enzyme is active as both a glycosyltransferase and an HCF-1 protease. Despite the reduction in OGT levels seen in the L254F-OGT individual cells, we observed that steady-state global O-GlcNAc levels remained grossly unaltered. Surprisingly, lymphoblastoids from affected individuals displayed a marked decrease in steady-state OGA protein and mRNA levels. We observed an enrichment of the OGT-containing transcriptional repressor complex mSin3A-HDAC1 at the proximal promoter region of OGA and correspondingly decreased OGA promoter activity in affected cells. Global transcriptome analysis of L254F-OGT lymphoblastoids compared with controls revealed a small subset of genes that are differentially expressed. Thus, we have begun to unravel the molecular consequences of the 759G>T (p.L254F) mutation in OGT that uncovered a compensation mechanism, albeit imperfect, given the phenotype of affected individuals, to maintain steady-state O-GlcNAc levels. Thus, a single amino acid substitution in the regulatory domain (the tetratricopeptide repeat domain) of OGT, which catalyzes the O-GlcNAc post-translational modification of nuclear and cytosolic proteins, appears causal for XLID.

          Related collections

          Author and article information

          Journal
          J Biol Chem
          J. Biol. Chem
          jbc
          jbc
          JBC
          The Journal of Biological Chemistry
          American Society for Biochemistry and Molecular Biology (11200 Rockville Pike, Suite 302, Rockville, MD 20852-3110, U.S.A. )
          0021-9258
          1083-351X
          26 May 2017
          16 March 2017
          : 292
          : 21
          : 8948-8963
          Affiliations
          From the []Department of Biochemistry and Molecular Biology, Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia 30602,
          the [§ ]McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University, Baltimore, Maryland 21287,
          the []Greenwood Genetic Center, Greenwood, South Carolina 29646,
          []Pediatrics (Medical Genetics), Pediatric Pathology, Human Genetics, Obstetrics, and Gynecology, University of Utah School of Medicine, Salt Lake City, Utah 84132,
          the [** ]Department of Paediatrics and Robinson Research Institute, University of Adelaide, Adelaide, South Australia 5006, Australia, and
          the [‡‡ ]Department of Computational Biophysics and Bioinformatics, Clemson University, Clemson, South Carolina 29634
          Author notes
          [1 ] To whom correspondence may be addressed. E-mail: ceschwartz@ 123456ggc.org .
          [2 ] To whom correspondence may be addressed. E-mail: lwells@ 123456ccrc.uga.edu .

          Edited by Eric R. Fearon

          Article
          PMC5448127 PMC5448127 5448127 M116.771030
          10.1074/jbc.M116.771030
          5448127
          28302723
          7bf1448c-de08-4c88-88c5-8319c2ea9e01
          © 2017 by The American Society for Biochemistry and Molecular Biology, Inc.
          History
          : 5 December 2016
          : 8 March 2017
          Funding
          Funded by: National Institute of General Medical Sciences , open-funder-registry 10.13039/100000057;
          Award ID: P41GM103490
          Funded by: National Institute of Neurological Disorders and Stroke , open-funder-registry 10.13039/100000065;
          Award ID: RO1NS073854
          Categories
          Glycobiology and Extracellular Matrices

          Comments

          Comment on this article